Using a differential subtractive hybridization cloning procedure we have recently identified the AP-2.2 gene as a novel early retinoic acid-induced gene in murine P19 embryonal carcinoma cells. We have also shown that the AP-2.2 protein, which is highly related to the AP-2 transcription factor, can activate transcription when bound to an AP-2 consensus binding site [Oulad-Abdelghani et al. (1995) Mol. Cell. Biol., submitted]. We report here the in situ hybridization pattern of expression of AP-2.2 transcripts during mouse embryogenesis. At 7.5 days post-co&urn, AP-2.2 transcripts were detected in the boundary region between neural plate and surface ectoderm, as well as in extra-embryonic tissues. By 8.0-8.5 gestational days, AP-2.2 transcripts appeared to be expressed in premigratory and migrating neural crest cells. Over the following days, the AP-2.2 gene displayed region-restricted expression in the facial mesenchyme, especially around the embryonic mouth cavity and the nasal cavities, as well as in the surface ectoderm, nasal and oral epithelia. AP-2.2 RNA was also specifically expressed in the presumptive cortical region of the forebrain vesicles. AP-2.2 transcripts were restricted to the distal mitotic area (the 'progress zone') of the limb buds and of the genital bud. AP-2.2 expression also appeared to be specific for primordial germ cells in the genital ridges. Thus, the AP-2.2 gene is expressed in several embryonic areas whose development can be affected by retinoids, such as the forebrain, face and limb buds.
Introduction
Vitamin A (retinol) and its active metabolite retinoic acid (RA) play important roles in vertebrate development through binding to two families of nuclear receptors, the RARs and RXRs (Chambon, 1994; Hofmann and Eichele, 1994; Kastner et al., 1994a; Linney and La Mantia, 1994; Lohnes et al., 1994; Mendelsohn et al., 1994a; Sucov et al., 1994 and references therein) . The retinoic acid receptors (RARs) can bind two stereoisomers, all-truns R4 and 9-cis RA, whereas the retinoid X receptors (RXRs) only bind 9-cis RA. These receptors bind to specific response elements as heterodimers and hence modulate the transcriptional activity of target genes (reviewed in Leid et al., 1992; Gig&e, 1994; Chambon, 1994; Kastner et al., 1994b; Mangelsdorf et al., 1994) .
So far, only a few RA target genes have been identified (reviewed in Gudas et al., 1994) . In order to isolate additional RA-responsive genes, we have used the P19 pluripotent embryonal carcinoma cell line as a model system. RA can induce these cells to differentiate into a neural, mesodermal or endodermal phenotype according to the RA concentration and the culture conditions used (McBurney and Rogers, 1982; MC Burney, 1993 and references therein) . Using a differential subtractive hybridization cloning strategy based on biotin-streptavidin affinity and the polymerase chain reaction (PCR), we isolated some 50 different cDNA clones whose corresponding transcripts are induced upon RA treatment of P19 cells (Bouillet et al., 1995) . One of these cDNAs encodes a novel protein which is highly related to the AP-2 transcription factor (66% overall amino acid identity with AP-2) and was therefore called AP-2.2 (Oulad- Abdelghani et al., 1995) . Interestingly, a central 96 amino acid region which corresponds to part of the AP-2 DNAbinding domain, is almost perfectly conserved between the two sequences.
The AP-2.2 protein was indeed shown to bind to a consensus AP-2 binding site and to mediate transactivation of a reporter gene construct containing such a site. Moreover, the AP-2.2 gene is induced in P19 cells within 30 min following RA administration, and is therefore considered as an 'immediate early' RA responsive gene (Oulad-Abdelghani et al., 1995) .
All of these AP-2.2 gene characteristics prompted us to study the expression pattern of the AP-2.2 gene during mouse embryogenesis. We report here that AP-2.2 transcripts display spatio-temporally restricted patterns of expression in the developing face, limbs, forebrain and genital system of the mouse, these domains being essentially distinct from those of the related AP-2 gene.
Results

I. AP-2.2 expression in early embryogenesis
The expression pattern of AP-2.2 was investigated by in situ hybridization on both whole-mount and sectioned embryos from 7.0 to 9.5 days post-coitum (dpc). Only extra-embryonic areas were labeled at 7.0 dpc (early primitive streak stage embryos). Strong signals were detected along the lining of the ectoplacental cavity and in the chorion (i.e. probably in the extra-embryonic ectoderm, Fig. 1A ). AP-2.2 was also expressed in the innermost cells of the decidua, and very strongly in the trophoblast giant cells (Fig. 1A) . Note that the same extraembryonic regions were strongly labeled at 8.5 dpc (Fig.  lB,C) . AP-2.2 expression was detected in the embryo proper at 7.5 dpc (early headfold stage) in the boundary region between neural plate and surface ectoderm ( Fig. 2A,B) . In 8.0 dpc embryos (4-6 somite pairs, beginning of neural tube closure), AP-2.2 expression was restricted to the dorsal edges of the neural groove (at both cranial and trunk levels), and to the adjacent headfold mesenchyme which contains the earliest migrating neural crest cells (NCC) (Fig. 2C and data not shown). At 8.5 dpc (8-12 somite pairs), AP-2.2 was still expressed along the dorsal edges of the neural folds and neural tube (Figs. lB, C and 2E, G, I) . In addition, AP-2.2 was clearly expressed in the lateral headfold (frontonasal) mesenchyme which mainly consists of forebrain-derived NCC (Figs. 1B and 2E, I) , as well as in cells adjacent to the 2nd and 4th rhombomeres (Fig. 2E,G) . Transverse sections showed that labeled cells extended from the dorsal neuroepithelium to the adjacent mesenchyme, as predicted for premigratory and migrating NCC (Fig. 2G,I ). The surface ectoderm was also labeled in the most rostra1 regions of the head (Fig. 21) .
AP-2.2 expression in the developing face
By 9.5-10.5 dpc, the rostra1 region of the embryo is transiently segmented into five symmetrical swellings called pharyngeal arches, which are essentially populated by mesectodermal NCC originating from the hindbrain and caudal midbrain, while the frontonasal mass is populated by rostral midbrain and forebrain NCC. At 9.5 dpc, AP-2.2 was preferentially expressed in specific regions of the frontonasal, maxillary, mandibular and 2nd arch mesenchyme, especially in the surrounding of the primitive mouth cavity (stomodaeum) (Figs. 25 and 3A) . There was also specific labeling in the various cranial nerve ganglia anlagen (Fig. 2J ). In contrast, the spinal nerve dorsal root ganglia did not express AP-2.2 (Fig. 25) .
AP-2.2 expression in facial mesenchyme clearly remained region-restricted during the following gestational days. By 11.5 dpc, specific expression was observed along the rostra1 aspect of the mandibular swellings and the caudal aspect of the maxillary swellings (Fig.  3B ,D,E). The areas of maximal expression along either side of the embryonic mouth cavity (stomodaeum) appeared to be centered around the dental laminae, epithelial thickenings from which the tooth buds will develop (Fig. 3E) . Labeling was also present in the prospective tongue area (Fig. 3E,F) . Specific mesenchymal labeling was also detected along each side of the grooves between the lateral nasal processes and the maxillary swellings, or nasolacrimal grooves ( Fig. 3D-F) . Within the nasal processes, AP-2.2 transcripts were preferentially distributed in the mesenchyme which surrounds the developing nasal cavities and in the presumptive respiratory epithelium (Fig. 3C,D) . AP-2.2 transcripts were also detected in the surface ectoderm of the face, as well as in the epithelium of the mouth cavity down to the oesophagus (Fig. 3E,F and data not shown). Hence, AP-2.2 transcripts seem to be associated with specific areas where facial shaping or local morphogenetic inductions (such as those leading to tooth formation) take place. Note that the cranial ganglia were not labeled any more at 11.5 dpc.
AP-2.2 expression in the developing brain
Region-restricted expression of AP-2.2 was observed in the dorsal forebrain neuroepithelium as early as 9.5 dpc, before or concomitantly to the evagination of the telencephalic vesicles (Figs. 2J and 3A) . Later (10.5-12.5 dpc), AP-2.2 expression was sharply restricted to the walls of the telencephalic vesicles ( Fig. 3B -F, 11.5 dpc). Along the rostro-caudal axis, the telencephalic expression stopped at the boundary with the diencephalon (Fig. 3E) , and along the dorso-ventral axis the expression boundary corresponded to the limit between the telencephalic walls and the striatum (Fig. 3B,D) . Thus, AP-2.2 transcripts precisely mark the area of the future cerebral cortex. AP-2.2 was also expressed at 11.5 dpc in part of the diencephalon, ventrally to the medial diencephalic sulcus, i.e. within the ventral thalamus ( Fig. 3F ). At the same stage, AP-2.2 was expressed in two columns of cells within the alar plates of the myelencephalon (Fig. 6H ) and more caudally in two thin symmetrical cell layers near the dorsal margin of the spinal cord (Figs. 4C and 6B, E, open arrows) . the distal cells underlying the apical ectodermal ridge (AER) (Fig. 4D ). The surface ectoderm and the AER were not labeled (Fig. 4D ). Hindlimb development is delayed with respect to that of the forelimb. Although, there were no visible hindlimb buds at 9.5 dpc, AP-2.2 transcripts were specifically expressed in the flank mesenthyme at the level of the presumptive hindlimb fields (Figs. 25 and 3A) . By 10.5 dpc, AP-2.2 expression in the hindlimb buds was similar to that observed in 9.5 dpc 2.4. AP-2.2 expression in the developing limbs AP-2.2 was specifically and transiently expressed during limb bud development. It was strongly expressed in the forelimb buds as soon as they become apparent by 9.5 dpc (Figs. 25 and 4A). Labeling was distributed across _ -the mesenchyme of the buds, with maximal intensity in forelimb buds (Fig. 4B ). During further limb development, AP-2.2 transcripts were restricted to the distal, highly mitotic mesenchyme or 'progress zone' (see the forelimbs in Fig. 4B ). A weaker expression was still detected in very distal limb mesenchyme at 11.5 dpc ( Fig.  4C and 6C ), whereas no labeling was seen at 12.5 and 13.5 dpc (not shown). Four serial frontal sections through the head of an 11.5 dpc embryo. AP-2.2 expression is restricted to the dorsal telencephalon, to the ventral thalamus (visible in (F)) and in discrete areas of the face (see the main text for details). Abbreviations: di, diencephalic vesicle; dl, dental laminae; dt, dorsal thalamus; e, eye; ec, surface ectoderm; fb, forebrain vesicle; fl, forelimb; hlf, hindlimb; hif, hindlimb field; ht, hypothalamus; mc, mouth cavity; md, mandibulary process; mx, maxillary process; nc, nasal cavities; nlg, nasolacrimal groove; np, nasal process; st, striatum; t, tongue area; te, telencephalic vesicle; vt, ventral thalamus. .5 dpc embryo. The signal is restricted to the dorsal part of the forebrain, some cranial NCC derivatives and the limb bud regions. There is artefactual staining due to antibody trapping in the otocyst cavity and the heart (as confied by ISH on sections). Abbreviations: A-P, antero-posterior axis; al, a2, first and second pharyngeal arches; am, amnion; ec, ectoderm; em, extraembryonic membranes; tb, forebrain; fg, foregut; fl, forelimb; fn, frontonasal mesenchyme; h, heart; hb, hindbrain; hf, headfolds; hlf, hindlimb field; md, mandibular process; ms, mesenchyme; mx, maxillary process; ne, neuroectoderm; nt, neural tube; o, otocyst; ps, primitive streak; r2, r4, rhombomeres 2 and 4; V, trigeminal ganglion; VII, VIII, facial-acoustic ganglion complex; IX, glossopharyngeal ganglion. Transverse section through the forelimbs of an 11.5 dpc embryo. Note the tendency towards a less intense and more distally restricted expression as forelimb development proceeds. The graded labeling in the neural tube appears to be artefactual, as it was not detected on adjacent sections. (D) High-power magnification of a 9.5 dpc forelimb bud as indicated by the boxed region in (A), showing the restricted and graded labeling in the mesenchyme. Abbreviations: AER, apical ectodermal ridge; b, brain; fl, forelimb; g, gut; h, heart; hl, hindlimb; ms, mesenthyme; n, neural tube; t, tail.
AP-2.2 expression in the developing urogenital system
The primordial germ cells (PGC) originate from the base of the allantois and migrate from 8.5 to 11.5 dpc along the wall of the gut tube and the dorsal mesentery to reach the presumptive gonad region or genital ridge. There was no sign of AP-2.2 expression in regions corresponding to migrating PGC prior to their arrival in the gonadal area (i.e. up to 10.5 dpc; not shown). However, a strong expression was detected in some cells of the genital ridge at 11.5 dpc (Fig. 5A,B) . Serial transverse sections showed a few labeled cells within the dorsal mesentery (Fig. 5B ). This pattern of expression indicates that AP-2.2 expression might be initiated in PGC by the end of their migration, when they are about to reach and colonize the genital ridge. This expression would be transient, as there was only weak expression in the seminiferous tubules of the fetal testis, and no detectable expression in the fetal ovary by 14.5-15.5 dpc (not shown). AP-2.2 transcripts were specifically detected in the epithelium and mesenchyme of the genital bud, precursor of the external genitalia, as soon as this structure appears (11.5 dpc, Figs. 5A and 6B,E) . The subsequent distribution of AP-2.2 transcripts towards the distal tip of the genital bud mesenchyme (Fig. 5C ) is reminiscent of that observed in the limb buds. AP-2.2 transcripts were also detected in the urethral and rectal epithelia (Fig. 5A,C) . Table 1 Comparative summary of AP-2.2 and AP-2 expression
Comparative analysis of ap-2 and ap-2.2 expression
We have compared AP-2 and AP-2.2 gene expression patterns at 8.0, 8.5,9.5, 11.5 and 13.5 dpc, using an AP-2 probe similar to that described by Mitchell et al. (1991) in a previous study (see Section 4) . A summary of these comparative data is provided in Table 1 .
Days post coitum
At 8.0 dpc, both genes displayed very similar expression patterns along the edges of the neural folds in presumptive premigratory NCC (Fig. 2C,D) . AP-2 expression levels were comparable to those of AP-2.2 in the head, but were lower in the trunk neural folds. At 8.5 dpc, both genes were expressed in cells of the frontonasal mesenchyme and in cells emanating from rhombomeres 2 and 4 (Fig. 2E,F) . We note that AP-2.2 expression was restricted to the vicinity of the hindbrain epithelium, whereas AP-2 expression extended down to the first pharyngeal arch (Fig. 2E-H) . At 9.5 dpc, both AP-2 and AP-2.2 were co-expressed in developing cranial ganglia. AP-2 expression was diffuse in the fiontonasal and pharyngeal arch mesenchyme, with no preferential transcript distribution as observed for AP-2.2 (data not shown). AP-2 signals were also much weaker than those of AP-2.2 in the limb bud mesenchyme (data not shown).
8.045
The analysis of serial cryosections at 11.5 dpc showed that AP-2 and AP-2.2 are co-expressed in the ventral thalamus (Fig. 6B,C) . Only AP-2.2 was expressed in the dorsal telencephalon (Fig. 6B,C ,E,F,K,L). On the other hand, AP-2 expression along the hindbrain and spinal cord was not shared by AP-2.2 (Fig. 6B,C,H,I ,K,L). Notice in this respect that the discrete expression domains of AP-2.2 in the myelencephalon and dorsal spinal cord cells correspond to areas of weak AP-2 expression (Fig. 6H,I and data not shown). At that stage, only AP-2 was expressed in the cranial and dorsal root ganglia (Fig. 6F) . Both gene expression patterns were mainly exclusive in facial mesenchymes: AP-2 was expressed in the mesenthyme of the nasal mass only, but its transcript distribution was distinct from that of AP-2.2 (compare Fig. 6B ,C and E,F). Both genes were expressed in the epidermis and the mouth cavity epithelium, and only AP-2.2 was expressed in the pharynx and oesophagus epithelium (Fig.  6H, arrow) . Both genes displayed similar expression domains in the distal extremities of the limbs but only AP-2 was expressed in a proximal medial patch (Fig. 6H,I , open arrows) as well as in the extremities of the limbs at 13.5 dpc (not shown). Both genes were also expressed in the genital bud (Fig. 6B,C,E,F) . Only AP-2.2, however, was expressed in the genital ridge (Fig. 6BC). 9.5 11.5 aWith distinct spatial distributions.
Discussion
Both AP-2 and AP-2.2 gene products are DNAbinding proteins which can bind to a common target site (Oulad-Abdelghani et al., 1995) . Hence, both genes might be expected to have partly redundant functions in areas where they are co-expressed during development. The present in situ analysis shows that AP-2 and AP-2.2 expression patterns are similar in early embryogenesis (8.0-8.5 dpc) but differ at later stages (see Table 1 AP-2 parative summary; see also Mitchell et al., 1991) . Both genes display similar early expression patterns at the dorsal edges of the cranial neural folds and in the adjacent dorsal mesenchyme. These similar expression patterns closely match the distribution of premigratory and early migrating cranial neural crest cells (NCC) and thus suggest possible redundant function(s) of both gene products in this cell population. There are, however, slight differences in the distribution of both gene transcripts at 8.5 dpc: AP-2.2 is preferentially expressed in cells which are close to the neuroepithelium, especially at the level of the 2nd and 4th rhombomeres, whereas AP-2 is preferentially expressed in more ventral cells such as the entire mesenchyme of the first pharyngeal arch. AP-2.2 expression at this stage is similar to that of the Slug zinc finger gene which was shown to be required for proper emigration of NCC from the neuroepithelium (Nieto et al., 1994) . We note, however, that the early expression phase of Slug in the flanks of the primitive streak is not shared by AP-2.2. The expression of AP-2 and AP-2.2 in various NCC derivatives clearly diverges at later stages (9.5-12.5 dpc). Both genes are transiently expressed in the developing cranial ganglia, but only AP-2 is detected in the spinal (dorsal root) ganglia. Whereas AP-2 is essentially expressed in the frontonasal mesenchyme, AP-2.2 expression is restricted to distinct areas of the facial mesenthyme, especially in the maxillo-mandibulary region. Thus, AP-2.2 expression seems to be either selectively maintained, or re-initiated, in some mesenchymal NCC after their migration. These appear to be located in areas where morphogenetic movements or local inductions take place, e.g. near the dental laminae. Hence, one major function of AP-2.2, which would not be redundant with AP-2, may be related to morphogenetic events in the embryonic face.
Both gene expression patterns are essentially distinct in the developing CNS. The only area of clear coexpression is the developing ventral thalamus at 11.5 dpc. In contrast, both genes have distinct expression domains in the hindbrain and spinal cord. Furthermore, only AP-2 shows restricted expression in the dorsal telencephalon. By 10.5-12.5 dpc, AP-2.2 transcripts precisely delimit the presumptive cerebral cortex, with sharp boundaries at the limit between cortical and non-cortical (basal) telencephalic regions. Thus, AP-2.2 may have a specific (nonredundant) function in defining the regional identity and/or the boundaries of the developing cerebral cortex. Other families of regulatory genes are expressed along domains whose boundaries are aligned with major subdivisions of the mammalian brain (reviewed in Puelles and Reubenstein, 1993) . In particular, the Emx and Ofx homeobox genes display nested expression domains that extend rostrally into the developing telencephalon (Simeone et al., 1992a (Simeone et al., ,b, 1993 . Emx-I gene expression is similar to that of AP-2.2 in its sharp restriction to the developing cerebral cortex (Simeone et al., 1992a) . On the other hand, Emx-2 and Otx transcript domains are clearly more extended than that of AP-2.2 (Simeone et al., 1993) . Thus, AP-2.2 may participate in forebrain patterning, and it will be particularly interesting to investigate Possible regulatory interactions between AP-2.2 and Em-l.
AP-2.2 is expressed in a dynamic manner during limb bud development, as its expression begins in the presumptive limb field shortly before budding and then becomes focused in the most distal limb mesenchyme. AP-2.2 gene expression is thus restricted to the so-called 'progress zone', a distal region of highly mitotic cells, which is known from experiments on avian limb buds to contain cells whose developmental fate has not yet been determined (Summerbell et al., 1973) . The proliferation of these cells is strictly dependent on the AER (Saunders, 1948) , a longitudinal thickening of the surface ectoderm which releases some growth-promoting factor(s). In turn, the progress, zone cells produce an 'apical ectodermal ridge maintenance factor' (AEMF) whose identity is yet unclear. AP-2.2 function in the developing limbs may be to control or maintain the growth potential in the buds by regulating the productiqn of an AEMF. AP-2.2 may actually cooperate with a number of other regulatory (DNAbinding) gene products such as msx-1 and -2 (Robert et al., 1989; Coehlo et al., 1991) or Hoxa and Hoxd gene products (Doll6 et al., 1989; Yokouchi et al., 1991) to provide growth and patterning information within the progress zone. We note that AP-2 and AP-2.2 are coexpressed, and thus might be partly redundant, in this region. As both genes appear to have distinct timings of expression during limb budding, AP-2.2 transcripts being detected earlier and disappearing before AP-2 transcripts, it seems that both gene activities may be required sequentially in cells of the progress zone. AP-2 may have an additional function related to its specific expression domain in a medial proximal patch of limb cells at 11.5-12.5 dpc.
As for the limbs, the genital tubercle is an appendicular structure which appears and grows through a budding mechanism. Several functional properties are shared both by the limb buds and the genital bud, such as growthpromoting activity of the surface epithelium, the presence of a polarizing activity or the coordinate expression of regulatory gene families (Murakami and Mizuno, 1986; DollC et al., 1991) . AP-2 and AP-2.2 are both expressed in the genital bud where they may perform the same basic function(s) as in developing limbs, in keeping with the proposal that various appendicular structures may use several common genetic systems for their growth and/or patterning (Doll6 et al., 1991) .
Altogether, AP-2.2 expression pattern is not tightly correlated to those of the various RARs and RXRs (Dollt et al., 1990 (Dollt et al., , 1994 Ruberte et al., 1990 Ruberte et al., , 1991 Ruberte et al., , 1993 . We note, however, that RARy is specifically expressed throughout the limb bud and facial mesenchymes, as well
